MP98-03 T-DM1, A NOVEL HER2 ANTIBODY-CYTOTOXIC DRUG CONJUGATE, HAS ANTI-METASTATIC POTENTIAL AND IS EFFECTIVE IN BLADDER CANCER WITH HER2 IHC SCORE 2+/3+